Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleAdjuvant Nivolumab or Ipilimumab + Nivolumab for Melanoma Determined by Pathological Response to a Single Dose of Neoadjuvant Nivolumab.AuthorsKhan, Tahsin M.; Teke, Martha E.; Karakousis, Giorgos C.; Miura, John T.; Brody, Robert M.; Hernandez, Jonathan M.; Mitchell, Tara C.PublicationAnnals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, Vol 29, Issue 5, p2771ISSN1068-9265Publication typeLetterDOI10.1245/s10434-021-11199-0